>50x family-selective CDK9 kinase inhibitor

IV agent (5-30 mg QW) in Ph. I for cancer

scaffold hop from atuveciclib

Journal of Medicinal Chemistry

Bayer, Berlin, DE / Vincerx, Palo Alto, US

Chemical structure of the VIP152 (BAY 1251152) inhibitor

The Vincerx Pharma/Bayer CDK9 inhibitor, VIP152 (BAY 1251152), is a once-weekly (5-30 mg) IV agent in Ph. I for cancer with >50x family-selectivity. The sulfoximine-containing molecule is derived from the oral…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: